-
SAMR Issued the Measures for the Administration of Imported Medicinal Materials
2019-05-17
To strengthen the administration and guarantee the quality of imported medicinal materials, on May 16, 2019, the State Administration for Market Regulation (SAMR) issued the revised Measures for the Administration of Imported Medicinal Materials (SAMR Order No. 9.
-
General Office of the State Council Issued the Opinions on Establishing a Team of Professionalized & Specialized Drug Inspectors
2019-07-19
Recently, the General Office of the State Council issued the Opinions on Establishing a Team of Professionalized & Specialized Drug Inspectors.
-
NMPA Issued the Announcement on Issues Concerning the Further Improvement of Drug-related Associated Review & Approval and Supervision
2019-07-16
NMPA issued the Announcement on Issues Concerning the Further Improvement of Drug-related Associated Review &Approval and Supervision.
-
NMPA Issued the Announcement on Medical Device GMP Appendix: Independent Software
2019-07-12
NMPA organized the drafting of and released on July 12, 2019 the Medical Device GMP Appendix: Independent Software.
-
NMPA Issued the Announcement on the Requirements for Filing Review of Registration Items of Medical Device Products (Interim)
2019-07-10
NMPA organized the formulation of the Requirements for Filing Review of Registration Items of Medical Device Products (Interim), which has been released on July 10, 2019, and shall enter into force as from September 1, 2019.
-
Provisions for Supervision of Drug Distribution
2019-07-25
The Provisions for Supervision of Drug Distribution, adopted at the executive meeting of the State Food and Drug Administration on December 8, 2006, is hereby promulgated and shall go into effect as of May 1, 2007.